Methylprednisolone succinate is a prodrug of Methylprednisolone and a glucocorticoid with immunosuppressant and anti-inflammatory activity. It functions by binding to cytosolic glucocorticoid receptors, modulating target gene transcription, and suppressing proinflammatory cytokine production and immune cell activation. This compound is researched for various conditions, including intracranial hemorrhage, rheumatoid arthritis, multiple sclerosis, and inflammatory states.
- Prodrug of Methylprednisolone.
- Possesses immunosuppressant and anti-inflammatory properties.
- Modulates target gene transcription.
- Suppresses proinflammatory cytokine production.
- Attenuates TLR4/NF-κB signaling.
- Researched for intracranial hemorrhage, rheumatoid arthritis, and multiple sclerosis.
- Available as a 10 mM solution in DMSO.